title: Does Postevacuation β -Human Chorionic Gonadotropin Level Predict the Persistent Gestational Trophoblastic Neoplasia?
abstract: β -human chorionic gonadotropin (HCG) level is not a reliable marker for early identification of persistent gestational trophoblastic neoplasia (GTN) after evacuation of hydatidiform mole. Thus, this study was conducted to evaluate β -HCG regression after evacuation as a predictive factor of malignant GTN in complete molar pregnancy. Methods. In this cross-sectional study, we evaluated a total of 260 patients with complete molar pregnancy. Sixteen of the 260 patients were excluded. Serum levels of HCG were measured in all patients before treatment and after evacuation. HCG level was measured weekly until it reached a level lower than 5 mIU/mL. Results. The only predictors of persistent GTN are HCG levels one and two weeks after evacuation. The cut-off point for the preevacuation HCG level was 6000 mIU/mL (area under the curve, AUC, 0.58; sensitivity, 38.53%; specificity, 77.4%), whereas cut-off points for HCG levels one and two weeks after evacuation were 6288 mIU/mL (AUC, 0.63; sensitivity, 50.46%; specificity, 77.0%) and 801 mIU/mL (AUC, 0.80; sensitivity, 79.82%; specificity, 71.64%), respectively. Conclusion. The rate of decrease of HCG level at two weeks after surgical evacuation is the most reliable and strongest predictive factor for the progression of molar pregnancies to persistent GTN.
authors.affiliation: Gynecology Oncology, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
authors.forename: Azam Sadat
authors.initials: AS
authors.lastname: Mousavi
authors.affiliation: Hormozgan Fertility & Infertility Research Center, Hormozgan University of Medical Sciences, Bandar Abbas 7914964157, Iran.
authors.forename: Samieh
authors.identifier: 0000-0002-6804-0389
authors.initials: S
authors.lastname: Karimi
authors.affiliation: Gynecology Oncology, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
authors.forename: Mitra
authors.initials: M
authors.lastname: Modarres Gilani
authors.affiliation: Gynecology Oncology, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
authors.forename: Setareh
authors.initials: S
authors.lastname: Akhavan
authors.affiliation: Vali-e-Asr Reproductive Health Research Center, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
authors.forename: Elahe
authors.initials: E
authors.lastname: Rezayof